Name:
EB Shield
Description:
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) |
Stage:
Recruiting
Principal Investigator:
Dr Fiona Browne
Sponsor:
TWi Biotechnology, Inc.
Network Partners
